David McDonnell

1.9k citations

68 papers · 1.3k indexed · h-index 19

Impact in

Psychiatry and Mental health top 1%
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
- Electroconvulsive Therapy Studies
- Epilepsy research and treatment
Biological Psychiatry top 5%

Papers in ⓘ

Psychiatry and Mental health 60
- Schizophrenia research and treatment 56
- Bipolar Disorder and Treatment 25
- Electroconvulsive Therapy Studies 9
Pharmacology 29
- Treatment of Major Depression 29

Co-authors: Holland C. Detke (20 shared papers)Daniel Lin (3 shared papers)Richard F. Bergstrom (2 shared papers)Adam Simmons (17 shared papers)Ying Jiang (19 shared papers)Fangyi Zhao (6 shared papers)Lei Sun (7 shared papers)John M. Kane (3 shared papers)
Journals: BMC Psychiatry (9 papers)CNS Spectrums (7 papers)The Journal of Clinical Psychiatry (6 papers)Schizophrenia Research (6 papers)Schizophrenia Bulletin (3 papers)
Partner nations: United States Ireland Germany

In The Last Decade

David McDonnell

65 papers receiving 1.3k citations

Peers

Countries citing papers authored by David McDonnell

Since Specialization

Citations

This map shows the geographic impact of David McDonnell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David McDonnell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David McDonnell more than expected).

Fields of papers citing papers by David McDonnell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David McDonnell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David McDonnell. The network helps show where David McDonnell may publish in the future.

Co-authors

The 25 scholars most cited alongside David McDonnell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David McDonnell Line = papers co-authored together David McDonnell links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 68 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Olanzapine Long-Acting Injection: A 24-Week, Randomized, Double-Blind Trial of Maintenance Treatment in Patients With Schizophrenia American Journal of Psychiatry ·John M. Kane, Holland C. Detke, Dieter Naber, Gopalan Sethuraman, Daniel Lin, Richard F. Bergstrom, David McDonnell	2009	157
2	An 8-Week, Double-Blind, Randomized, Placebo-Controlled Study of Olanzapine Long-Acting Injection in Acutely Ill Patients With Schizophrenia The Journal of Clinical Psychiatry ·John Lauriello, Tim Lambert, Scott W. Andersen, Daniel Lin, Cindy C. Taylor, David McDonnell	2008	97
3	Randomised, double-blind, placebo-controlled study of olanzapine in patients with bipolar I depression The British Journal of Psychiatry ·Mauricio Tohen, David McDonnell, Michael Case, Shigenobu Kanba, Kyooseob Ha, Yi Fang, Hideaki Katagiri, Juan Carlos Gómez	2012	93
4	Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, I: analysis of cases BMC Psychiatry ·Holland C. Detke, David McDonnell, Eric J. Brunner, Fangyi Zhao, Sebastian Sorsaburu, Victoria Jennifer Stefaniak, S. Corya	2010	82
5	Effects of Olanzapine Combined With Samidorphan on Weight Gain in Schizophrenia: A 24-Week Phase 3 Study American Journal of Psychiatry ·Christoph U. Correll, John W. Newcomer, Bernard L. Silverman, Lauren DiPetrillo, Christine Graham, Ying Jiang, Yangchun Du, Adam Simmons, Craig Hopkinson, David McDonnell, René S. Kahn	2020	80
6	Post-injection delirium/sedation syndrome in patients with schizophrenia treated with olanzapine long-acting injection, II: investigations of mechanism BMC Psychiatry ·David McDonnell, Holland C. Detke, Richard F. Bergstrom, Prajakti A. Kothare, Jason T. Johnson, Mary P. Stickelmeyer, Manuel Sánchez-Félix, Sebastian Sorsaburu, Malcolm I. Mitchell	2010	64
7	Classifying Patients by Antipsychotic Adherence Patterns Using Latent Class Analysis: Characteristics of Nonadherent Groups in the California Medicaid (Medi-Cal) Program Value in Health ·Jeonghoon Ahn, Jeffrey S. McCombs, Changun Jung, Tim Croudace, David McDonnell, Haya Ascher‐Svanum, E.T. Edgell, Lizheng Shi	2007	56
8	D2 Receptor Occupancy of Olanzapine Pamoate Depot Using Positron Emission Tomography: An Open-label Study in Patients with Schizophrenia Neuropsychopharmacology ·David C. Mamo, Shitij Kapur, Matcheri S. Keshavan, Marc Laruelle, Cindy C. Taylor, Prajakti A. Kothare, Penny Barsoum, David McDonnell	2007	53
9	Efficacy and Safety of a Combination of Olanzapine and Samidorphan in Adult Patients With an Acute Exacerbation of Schizophrenia The Journal of Clinical Psychiatry ·Steven G. Potkin, Jelena Kunovac, Bernard L. Silverman, Adam Simmons, Ying Jiang, Lauren DiPetrillo, David McDonnell	2020	47
10	<p>A commentary on the efficacy of olanzapine for the treatment of schizophrenia: the past, present, and future</p> Neuropsychiatric Disease and Treatment ·Leslie Citrome, Joseph P. McEvoy, Mark S. Todtenkopf, David McDonnell, Peter J. Weiden	2019	46
11	A phase 3, multicenter study to assess the 1-year safety and tolerability of a combination of olanzapine and samidorphan in patients with schizophrenia: Results from the ENLIGHTEN-2 long-term extension Schizophrenia Research ·René S. Kahn, Bernard L. Silverman, Lauren DiPetrillo, Christine Graham, Ying Jiang, Jiani C. Yin, Adam Simmons, Vasudev Bhupathi, Bei Yu, Sergey Yagoda, Craig Hopkinson, David McDonnell	2021	33
12	Pharmacokinetics and Short-term Safety of ALKS 3831, a Fixed-dose Combination of Olanzapine and Samidorphan, in Adult Subjects with Schizophrenia Clinical Therapeutics ·Lei Sun, David McDonnell, Lisa Von Moltke	2018	31
13	Comparison of metabolic changes in patients with schizophrenia during randomized treatment with intramuscular olanzapine long‐acting injection versus oral olanzapine Human Psychopharmacology Clinical and Experimental ·David McDonnell, Ludmila Kryzhanovskaya, Fangyi Zhao, Holland C. Detke, Peter D. Feldman	2011	25
14	Dose correspondence between olanzapine long-acting injection and oral olanzapine International Clinical Psychopharmacology ·Holland C. Detke, Fangyi Zhao, Parag Garhyan, Janice Carlson, David McDonnell	2010	23
15	Long-term safety and efficacy of olanzapine long-acting injection in patients with schizophrenia or schizoaffective disorder International Clinical Psychopharmacology ·David McDonnell, John Landry, Holland C. Detke	2014	22
16	Bioequivalence of Olanzapine Given in Combination With Samidorphan as a Bilayer Tablet (ALKS 3831) Compared With Olanzapine‐Alone Tablets: Results From a Randomized, Crossover Relative Bioavailability Study Clinical Pharmacology in Drug Development ·Lei Sun, David McDonnell, Jianjun Liu, Lisa Von Moltke	2018	22
17	Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia BMC Psychiatry ·Angela Hill, Bin Sun, Jamie Karagianis, Susan B. Watson, David McDonnell	2011	20
18	Long-term safety and durability of effect with a combination of olanzapine and samidorphan in patients with schizophrenia: results from a 1-year open-label extension study CNS Spectrums ·Sergey Yagoda, Christine Graham, Adam Simmons, Christina Arevalo, Ying Jiang, David McDonnell	2020	20
19	Single- and Multiple-Dose Pharmacokinetic, Safety, and Tolerability Profiles of Olanzapine Long-Acting Injection: An Open-Label, Multicenter, Nonrandomized Study in Patients With Schizophrenia Clinical Therapeutics ·Malcolm I. Mitchell, Prajakti A. Kothare, Richard Bergstrom, Fangyi Zhao, Kai Yu Jen, Daniel Walker, Jason T. Johnson, David McDonnell	2013	20
20	Olanzapine Plus Samidorphan (ALKS 3831) in Schizophrenia and Comorbid Alcohol Use Disorder The Journal of Clinical Psychiatry ·Mary F. Brunette, Christoph U. Correll, Stephanie S O'Malley, David McDonnell, Lauren DiPetrillo, Ying Jiang, Adam Simmons, Bernard L. Silverman, Leslie Citrome, Alan I. Green	2020	18

About David McDonnell

David McDonnell is a scholar working on Psychiatry and Mental health, Pharmacology, Philosophy, Physiology and Clinical Psychology, having authored 68 papers that have together received 1.3k indexed citations. Recurring topics across this work include Schizophrenia research and treatment (56 papers), Treatment of Major Depression (29 papers), Bipolar Disorder and Treatment (25 papers), Electroconvulsive Therapy Studies (9 papers), Mental Health and Psychiatry (8 papers), Diet and metabolism studies (7 papers), Tryptophan and brain disorders (4 papers) and Pharmaceutical studies and practices (4 papers). The work is most often cited by research in Psychiatry and Mental health (1.1k citations), Biological Psychiatry (87 citations), Pharmacology (374 citations), Philosophy (153 citations) and Clinical Psychology (213 citations). David McDonnell has collaborated with scholars based in United States, Ireland and Germany. Frequent co-authors include Holland C. Detke, Daniel Lin, Richard F. Bergstrom, Adam Simmons, Ying Jiang, Fangyi Zhao, Lei Sun, John M. Kane, Lauren DiPetrillo and Lisa Von Moltke. Their work appears in journals such as BMC Psychiatry, CNS Spectrums, The Journal of Clinical Psychiatry, Schizophrenia Research and Schizophrenia Bulletin.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact